Attovia Therapeutics market cap: $972.372 M

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

#48Odyssey TherapeuticsODTX$1.11B
#49Monte Rosa TherapeuticsGLUE$1.05B
#50Attovia TherapeuticsATTO$972.4M
#51SL ScienceSLBT$964.5M
#52Sana BiotechnologySANA$928.0M

Insiders buying

6 open-market purchases by officers and directors of Attovia Therapeutics, worth $52.4M. Grants and option exercises are excluded.

Broad Street Principal Investments, L.L.C., GOLDMAN SACHS & CO. LLC, GOLDMAN SACHS ASSET MANAGEMENT, L.P., GOLDMAN SACHS GROUP INC, WSLS EMP OFFSHORE INVESTMENTS, L.P., WSLS EMP ONSHORE INVESTMENTS, L.P., WSLS OFFSHORE INVESTMENTS, SLP, West Street Life Sciences I, L.P.$10.3M
585,000 shares at $17.58 on 5 Aug 2026 · filed 13 Aug 2026
Colin Walsh$10.3M
585,000 shares at $17.58 on 5 Aug 2026 · filed 13 Aug 2026
venBio Global Strategic Fund IV, L.P.$6.50M
382,352 shares at $17.00 on 6 Aug 2026 · filed 10 Aug 2026
Jeremy Green, Redmile Biopharma Investments III, L.P., Redmile Group, LLC$10.2M
600,000 shares at $17.00 on 6 Aug 2026 · filed 7 Aug 2026
Sanofi$5.10M
300,000 shares at $17.00 on 6 Aug 2026 · filed 7 Aug 2026
FHMLS XI, L.L.C., FHMLS XI, L.P., Frazier Life Sciences XI, L.P.$10.00M
588,235 shares at $17.00 on 6 Aug 2026 · filed 6 Aug 2026

What if Attovia Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$663,159.19

Per share 31,134× higher

Bitcoin $1.72T

$37,672.64

Per share 1,769× higher

Nvidia $5.48T

$120,037.38

Per share 5,636× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for Attovia Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.